All Updates

All Updates

icon
Filter
Product updates
H1 launches GenAI tool to accelerate clinical trials
Clinical Trial Technology
Oct 5, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Oct 5, 2023

H1 launches GenAI tool to accelerate clinical trials

Product updates

  • H1, a clinical trial intelligence platform provider, has launched GenosAI, an AI tool embedded into its platform, Trial Landscape. The platform helps to analyze complex inquiries related to clinical trials.

  • GenosAI offers insights into competing trials, streamlines site selection, promotes diversity in clinical trials, assists with site selection and feasibility assessments, improves trial design, and breaks down data barriers.

  • H1 is a provider of several platforms to assist with carrying out clinical trials. The company has four platforms that help with providing insights into different aspects of clinical trials, including key opinion leader identification and engagement, performance, site selection and diversity, data management, and claims-based settlements. The company claims that its Trial Landscape platform generates insights based on the results of 490,000 trials, 25 million publications, 10 million healthcare providers, 240 million patients, and 11 billion global claims. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.